Q/C Technologies Inc Com Par $0.001 (QCLS:NASDAQ) closed at $0.467 on October 27, 2026, up 2.66% on the day. The stock trades 94.3% below its 52-week high of $8.17 and 11.2% above its 52-week low of $0.420. Over the past year, it lost 87.8%. Q/C Technologies Inc Com Par $0.001 is part of the Health Care sector.
In 252 trading sessions since October 27, 2025, QCLS closed higher on 104 days (41%). Its best day was September 16, 2026 (+118.59%) and its worst was September 14, 2026 (-67.25%). The stock moved 10% or more in a single session 35 times. It opened at least 5% above the previous day's high 4 times.
TNF Pharmaceuticals, Inc. (Nasdaq: TNFA), is a clinical stage pharmaceutical company committed to extending healthy lifespan. We are focused on developing two novel therapeutic platforms that treat the causes of disease rather than only addressing the symptoms. MYMD-1 is a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-alpha, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. MYMD-1 is being developed to treat diseases and disorders marked by acute or chronic inflammation. Our second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction and epilepsy. Supera-CBD is a novel synthetic derivative of cannabidiol (CBD) and is being developed to address and improve upon the rapidly growing CBD market, which includes both FDA approved drugs and CBD products not currently regulated as drugs.
Find more stocks like QCLS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.